1. Home
  2. CFBK vs QTRX Comparison

CFBK vs QTRX Comparison

Compare CFBK & QTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CF Bankshares Inc.

CFBK

CF Bankshares Inc.

HOLD

Current Price

$33.91

Market Cap

178.1M

Sector

Finance

ML Signal

HOLD

Logo Quanterix Corporation

QTRX

Quanterix Corporation

HOLD

Current Price

$3.66

Market Cap

160.0M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
CFBK
QTRX
Founded
1892
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Laboratory Analytical Instruments
Sector
Finance
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
178.1M
160.0M
IPO Year
2005
2017

Fundamental Metrics

Financial Performance
Metric
CFBK
QTRX
Price
$33.91
$3.66
Analyst Decision
Buy
Hold
Analyst Count
2
2
Target Price
$31.50
$6.00
AVG Volume (30 Days)
64.1K
575.1K
Earning Date
05-08-2026
05-06-2026
Dividend Yield
1.23%
N/A
EPS Growth
30.58
N/A
EPS
0.77
N/A
Revenue
N/A
$37,632,000.00
Revenue This Year
$31.99
$25.49
Revenue Next Year
$9.09
$10.04
P/E Ratio
$43.43
N/A
Revenue Growth
N/A
64.52
52 Week Low
$22.10
$2.40
52 Week High
$34.34
$8.77

Technical Indicators

Market Signals
Indicator
CFBK
QTRX
Relative Strength Index (RSI) 71.06 46.70
Support Level $28.40 $3.30
Resistance Level N/A $3.81
Average True Range (ATR) 0.90 0.30
MACD 0.03 -0.07
Stochastic Oscillator 66.67 5.21

Price Performance

Historical Comparison
CFBK
QTRX

About CFBK CF Bankshares Inc.

CF Bankshares Inc is engaged in the provision of a variety of financial services. It provides personalized business banking products and services, including commercial loans and leases, commercial and residential real estate loans, equipment leasing, SBA loans, and treasury management depository services. The revenues are derived principally from the interest and fees on loans originated and noninterest income generated on the sale of loans.

About QTRX Quanterix Corporation

Quanterix Corp is a life sciences company accelerating biomarker breakthroughs from discovery to diagnostics using ultra-sensitive translational research and spatial biology instruments, consumables, and services. The company sells proprietary instruments and related consumables to research laboratories, contract research organizations (CROs), academic institutions, and bio-pharmaceutical companies, and provides contract research services and clinical laboratory testing services, including four Laboratory Developed Tests (LDTs), through its Accelerator Laboratory. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, and SP-X Imaging and Analysis System. Geographically, it operates in North America, EMEA, and the Asia Pacific.

Share on Social Networks: